vimarsana.com
Home
Live Updates
SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathy : vimarsana.com
SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathy
PHILADELPHIA--(BUSINESS WIRE)--Oct 4, 2023--
Related Keywords
Netherlands ,
United States ,
United Kingdom ,
Italy ,
France ,
Spain ,
Germany ,
David Weiner ,
Lara Furst ,
Chris Hollowood ,
European Medicines Agency ,
Central Committee On Research Involving Human Subjects ,
Drug Administration ,
Syncona Ltd ,
Syncona Investment Management ,
Bio Therapeutics ,
Data Safety Monitoring Board ,
Syncona Investment Management Limited ,
Clinical Trial Application ,
Central Committee ,
Research Involving Human Subjects ,
Fast Track ,
Orphan Drug Designation ,
European Medicines ,
Mass General Brigham ,
Business Wire ,
Region ,
vimarsana.com © 2020. All Rights Reserved.